Company: CERO
Filing Date: 2025-05-27
Form Type: POS AM
Source: 0001213900-25-047469
Chunk: 296

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-27
Form: POS AM
Chunk 296
---
 of our Common Stock or Warrants then 
 outstanding, as applicable; or                                        |

| ● | the average weekly reported trading volume of our Common Stock or our                                                          
 Warrants, as applicable, during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale. |

Sales by our affiliates under Rule 144 are also limited by manner of sale provisions and notice requirements and to the availability of current public information about us. Restrictions on the Use of Rule 144 by Shell Companies or Former Shell Companies Rule 144 is not available for the resale of securities initially issued by shell companies (other than business-combination related shell companies) or issuers that have been at any time previously a shell company. However, Rule 144 also includes an important exception to this prohibition if the following conditions are met:

| ● | the issuer of the securities that was formerly a shell company has 
 ceased to be a shell company;                                      |

| ● | the issuer of the securities is subject to the reporting requirements                                                             
 of Section 13 or 15(d) of the Exchange Act;                                                                                       |
| ● | the issuer of the securities has filed all Exchange Act reports and                                                               
 material required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required 
 to file such reports and materials) other than Form 8-K reports; and                                                              |

| ● | at least one year has elapsed from the time that the issuer filed current                             
 Form 10-type information with the SEC reflecting its status as an entity that is not a shell company. |

We are no longer a shell company and, as a result, once the conditions set forth in the exceptions listed above are satisfied, Rule 144 will become available for the resale of shares of Common Stock. Registration Rights Each of the Investor Rights Agreement, the Keystone Registration Rights Agreements, the Arena Purchase Agreement, the Fee Modification Agreements and the Liquidated Damages Modification Agreement provides for certain registration rights. For additional information, see the subsections entitled “ Description of Securities-Registration Rights.” 170 PLAN OF DISTRIBUTION The Common Stock offered by this prospectus are being offered by the Selling Securityholder. The shares may be sold or distributed from time to time by the Selling Securityholder directly to one or more purchasers or through brokers, dealers, or underwriters who may act solely as agents at market prices prevailing at the time of sale, at prices related to the prevailing market prices, at negotiated prices, or at fixed prices